272110 Stock Chart & Stats
₩26300.00
-₩1,700.00(-6.07%)
―
--
Day’s Range― - ―
52-Week Range₩15,300.00 - ₩44,600.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)106.86K
Market Cap
₩205.55B
Enterprise Value₩360.34K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)7.5
Beta0.32
Next Earnings
Nov 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding8,025,395
10 Day Avg. Volume75,903
30 Day Avg. Volume106,855
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
272110 FAQ
What was KnJ Co., Ltd.’s price range in the past 12 months?
KnJ Co., Ltd. lowest stock price was ₩15300.00 and its highest was ₩44600.00 in the past 12 months.
What is KnJ Co., Ltd.’s market cap?
KnJ Co., Ltd.’s market cap is ₩205.55B.
When is KnJ Co., Ltd.’s upcoming earnings report date?
KnJ Co., Ltd.’s upcoming earnings report date is Nov 05, 2026 which is in 80 days.
How were KnJ Co., Ltd.’s earnings last quarter?
Currently, no data Available
Is KnJ Co., Ltd. overvalued?
According to Wall Street analysts KnJ Co., Ltd.’s price is currently Undervalued.
Does KnJ Co., Ltd. pay dividends?
KnJ Co., Ltd. does not currently pay dividends.
What is KnJ Co., Ltd.’s EPS estimate?
KnJ Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does KnJ Co., Ltd. have?
KnJ Co., Ltd. has 8,025,395 shares outstanding.
What happened to KnJ Co., Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of KnJ Co., Ltd.?
Currently, no hedge funds are holding shares in KR:272110
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dx & Vx Co., Ltd.
―
Boditech Med, Inc.
―
KANGSTEM BIOTECH Co., Ltd.
―
S.Biomedics Co., Ltd.
―
EASY BIO, Inc.
―